Company profile

SK bioscience

We promote human health, from Prevention to Cure

Industry
Biotechnology Research
Employees
454
Headquarters
Incheon
Founded
2018
Office locations
1

SK bioscience company summary

SK bioscience is a company in the Biotechnology Research industry, headquartered in Incheon, founded in 2018. On LinkedIn the company has around 454 employees.

What technology does SK bioscience use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About SK bioscience

At SK bioscience, we work every day to promote human health—from prevention to cure. We are a global vaccine and biotech company with a proven track record in developing, manufacturing, and supplying innovative vaccines for infectious diseases. SK bioscience successfully developed South Korea’s first COVID-19 vaccine, SKYCovione, through global collaboration with partners including CEPI, the Bill & Melinda Gates Foundation, and GSK. We have also advanced the development of a next-generation universal vaccine targeting sarbecoviruses. Our innovation leadership is demonstrated by a robust portfolio: SKYCellflu, the world’s first quadrivalent cell-cultured influenza vaccine to obtain WHO Prequalification; SKYZoster, the world’s second herpes zoster vaccine; and SKYVaricella, the world’s second WHO PQ-certified varicella vaccine. These achievements reflect our long-standing expertise in vaccine science and global regulatory capabilities. SK bioscience continues to expand its R&D pipeline across pneumococcal conjugate vaccines, mRNA-based vaccines, and vaccines for cervical cancer, typhoid, rotavirus, and other infectious diseases—through strategic partnerships with global public and private institutions. Our state-of-the-art vaccine manufacturing plant, L HOUSE, is a global hub for vaccine production, equipped with end-to-end capabilities spanning drug substance and drug product manufacturing. Designed to meet the highest international quality and regulatory standards, L HOUSE enables rapid, large-scale, and flexible vaccine production to respond to global public health needs. During the COVID-19 pandemic, the facility played a critical role in supporting large-scale manufacturing for partners such as AstraZeneca, reinforcing SK bioscience’s position as a trusted partner in global vaccine supply and pandemic preparedness. Guided by scientific excellence and trusted partnerships, our people are united by a single mission: to advance global health and create sustaina

Where is SK bioscience located?

SK bioscience lists 1 location.

Incheon, 21984, KRHQ
38, Yeongudanji-ro, Yeonsu-gu

Compare companies similar to SK bioscience

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
SK bioscience
skbioscience.com
Biotechnology Research4542018Incheon
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about SK bioscience

What does SK bioscience do?

At SK bioscience, we work every day to promote human health—from prevention to cure. We are a global vaccine and biotech company with a proven track record in developing, manufacturing, and supplying innovative vaccines for infectious diseases. SK bioscience successfully developed South Korea’s first COVID-19 vaccine, SKYCovione, through global collaboration with partners including CEPI, the Bill & Melinda Gates Foundation, and GSK. We have also advanced the development of a next-generation universal vaccine targeting sarbecoviruses. Our innovation leadership is demonstrated by a robust portfolio: SKYCellflu, the world’s first quadrivalent cell-cultured influenza vaccine to obtain WHO Prequalification; SKYZoster, the world’s second herpes zoster vaccine; and SKYVaricella, the world’s second WHO PQ-certified varicella vaccine. These achievements reflect our long-standing expertise in vaccine science and global regulatory capabilities. SK bioscience continues to expand its R&D pipeline across pneumococcal conjugate vaccines, mRNA-based vaccines, and vaccines for cervical cancer, typhoid, rotavirus, and other infectious diseases—through strategic partnerships with global public and private institutions. Our state-of-the-art vaccine manufacturing plant, L HOUSE, is a global hub for vaccine production, equipped with end-to-end capabilities spanning drug substance and drug product manufacturing. Designed to meet the highest international quality and regulatory standards, L HOUSE enables rapid, large-scale, and flexible vaccine production to respond to global public health needs. During the COVID-19 pandemic, the facility played a critical role in supporting large-scale manufacturing for partners such as AstraZeneca, reinforcing SK bioscience’s position as a trusted partner in global vaccine supply and pandemic preparedness. Guided by scientific excellence and trusted partnerships, our people are united by a single mission: to advance global health and create sustaina

How many employees does SK bioscience have?

SK bioscience has around 454 employees on LinkedIn.

Where is SK bioscience headquartered?

SK bioscience is headquartered in Incheon.

When was SK bioscience founded?

SK bioscience was founded in 2018.

Build a lead list from companies like SK bioscience

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.